×
S&P 500   4,158.24 (+2.47%)
DOW   33,212.96 (+1.76%)
QQQ   309.10 (+3.26%)
AAPL   149.64 (+4.08%)
MSFT   273.24 (+2.76%)
FB   195.13 (+1.83%)
GOOGL   2,246.33 (+4.20%)
AMZN   2,302.93 (+3.66%)
TSLA   759.63 (+7.33%)
NVDA   188.11 (+5.38%)
BABA   93.41 (-1.13%)
NIO   16.57 (+3.37%)
AMD   102.26 (+3.55%)
CGC   4.88 (-12.07%)
MU   73.32 (+3.85%)
T   21.29 (-0.14%)
GE   78.76 (+2.27%)
F   13.63 (+3.89%)
DIS   109.32 (+3.51%)
AMC   14.43 (+17.99%)
PFE   53.91 (-0.15%)
PYPL   85.21 (+5.96%)
NFLX   195.19 (+1.98%)
S&P 500   4,158.24 (+2.47%)
DOW   33,212.96 (+1.76%)
QQQ   309.10 (+3.26%)
AAPL   149.64 (+4.08%)
MSFT   273.24 (+2.76%)
FB   195.13 (+1.83%)
GOOGL   2,246.33 (+4.20%)
AMZN   2,302.93 (+3.66%)
TSLA   759.63 (+7.33%)
NVDA   188.11 (+5.38%)
BABA   93.41 (-1.13%)
NIO   16.57 (+3.37%)
AMD   102.26 (+3.55%)
CGC   4.88 (-12.07%)
MU   73.32 (+3.85%)
T   21.29 (-0.14%)
GE   78.76 (+2.27%)
F   13.63 (+3.89%)
DIS   109.32 (+3.51%)
AMC   14.43 (+17.99%)
PFE   53.91 (-0.15%)
PYPL   85.21 (+5.96%)
NFLX   195.19 (+1.98%)
S&P 500   4,158.24 (+2.47%)
DOW   33,212.96 (+1.76%)
QQQ   309.10 (+3.26%)
AAPL   149.64 (+4.08%)
MSFT   273.24 (+2.76%)
FB   195.13 (+1.83%)
GOOGL   2,246.33 (+4.20%)
AMZN   2,302.93 (+3.66%)
TSLA   759.63 (+7.33%)
NVDA   188.11 (+5.38%)
BABA   93.41 (-1.13%)
NIO   16.57 (+3.37%)
AMD   102.26 (+3.55%)
CGC   4.88 (-12.07%)
MU   73.32 (+3.85%)
T   21.29 (-0.14%)
GE   78.76 (+2.27%)
F   13.63 (+3.89%)
DIS   109.32 (+3.51%)
AMC   14.43 (+17.99%)
PFE   53.91 (-0.15%)
PYPL   85.21 (+5.96%)
NFLX   195.19 (+1.98%)
S&P 500   4,158.24 (+2.47%)
DOW   33,212.96 (+1.76%)
QQQ   309.10 (+3.26%)
AAPL   149.64 (+4.08%)
MSFT   273.24 (+2.76%)
FB   195.13 (+1.83%)
GOOGL   2,246.33 (+4.20%)
AMZN   2,302.93 (+3.66%)
TSLA   759.63 (+7.33%)
NVDA   188.11 (+5.38%)
BABA   93.41 (-1.13%)
NIO   16.57 (+3.37%)
AMD   102.26 (+3.55%)
CGC   4.88 (-12.07%)
MU   73.32 (+3.85%)
T   21.29 (-0.14%)
GE   78.76 (+2.27%)
F   13.63 (+3.89%)
DIS   109.32 (+3.51%)
AMC   14.43 (+17.99%)
PFE   53.91 (-0.15%)
PYPL   85.21 (+5.96%)
NFLX   195.19 (+1.98%)
NYSEARCA:ARKG

ARK Genomic Revolution Multi-Sector ETF (ARKG) Stock Forecast, Price & News

$33.64
+1.73 (+5.42%)
(As of 05/27/2022 12:00 AM ET)
Add
Today's Range
$31.73
$33.65
50-Day Range
$28.08
$48.94
52-Week Range
$27.47
$94.14
Volume
4.13 million shs
Average Volume
3.93 million shs
Market Capitalization
$2.58 billion
P/E Ratio
N/A
Dividend Yield
1.20%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive ARKG News and Ratings via Email

Sign-up to receive the latest news and ratings for ARK Genomic Revolution Multi-Sector ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer ARK
Fund NameARK Genomic Revolution Multi-Sector ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:ARKG
Inception Date10/30/2014
Fund ManagerCatherine D. Wood
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkNot Applicable
CategoryStrategy
FocusTheme
Development LevelBlended Development
RegionGlobal

Fund Statistics

Assets Under Management$2.52 billion
Average Daily Volume$5.03 million
Discount/Premium0.01%

ETF Expenses

Management Fee0.75%
Other Expenses0.00%
Total Expenses0.75%
Fee Waiver0.00%
Net Expenses0.75%

Administrator, Advisor and Custodian

AdministratorThe Bank of New York Mellon Corporation
AdvisorARK Investment Management LLC
CustodianThe Bank of New York Mellon Corporation
DistributorForeside Fund Services, LLC
Transfer AgentThe Bank of New York Mellon Corporation
Trustee
Lead Market MakerJane Street

Geographic Exposure of ARKG

Currency Exposure of ARKG

Sector Exposure of ARKG

Industry Exposure of ARKG














ARK Genomic Revolution Multi-Sector ETF (NYSEARCA:ARKG) Frequently Asked Questions

Is ARK Genomic Revolution Multi-Sector ETF a good dividend stock?

ARK Genomic Revolution Multi-Sector ETF pays an annual dividend of $0.38 per share and currently has a dividend yield of 1.20%.
View ARK Genomic Revolution Multi-Sector ETF's dividend history.

What other stocks do shareholders of ARK Genomic Revolution Multi-Sector ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ARK Genomic Revolution Multi-Sector ETF investors own include Tesla (TSLA), ARK Innovation ETF (ARKK), NVIDIA (NVDA), ARK Next Generation Internation ETF (ARKW), Alibaba Group (BABA), Intel (INTC), PayPal (PYPL), Alphabet (GOOG), Netflix (NFLX) and Square (SQ).

What is ARK Genomic Revolution Multi-Sector ETF's stock symbol?

ARK Genomic Revolution Multi-Sector ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "ARKG."

Who are ARK Genomic Revolution Multi-Sector ETF's major shareholders?

ARK Genomic Revolution Multi-Sector ETF's stock is owned by a number of institutional and retail investors. Top institutional investors include Goldman Sachs Group Inc. (0.00%), Jane Street Group LLC (0.00%), JPMorgan Chase & Co. (0.31%), Cambridge Investment Research Advisors Inc. (0.28%), Cutler Group LP (0.00%) and Main Management ETF Advisors LLC (0.19%).

Which major investors are selling ARK Genomic Revolution Multi-Sector ETF stock?

ARKG stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., JPMorgan Chase & Co., PEAK6 Investments LLC, HAP Trading LLC, Cambridge Investment Research Advisors Inc., Cutler Group LP, SOA Wealth Advisors LLC., and SG Americas Securities LLC.

Which major investors are buying ARK Genomic Revolution Multi-Sector ETF stock?

ARKG stock was acquired by a variety of institutional investors in the last quarter, including Walleye Trading LLC, Rothschild Investment Corp IL, Jane Street Group LLC, Main Management ETF Advisors LLC, Patriot Investment Management Inc., Tcwp LLC, Next Capital Management LLC, and Baird Financial Group Inc..

How do I buy shares of ARK Genomic Revolution Multi-Sector ETF?

Shares of ARKG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ARK Genomic Revolution Multi-Sector ETF's stock price today?

One share of ARKG stock can currently be purchased for approximately $33.64.

How much money does ARK Genomic Revolution Multi-Sector ETF make?

ARK Genomic Revolution Multi-Sector ETF has a market capitalization of $2.58 billion.

This page was last updated on 5/27/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.